Related Experiment Video
Updated: Aug 22, 2026

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
Review article: inflammatory bowel disease--empowering the patient and improving outcome
1Department of Gastrointestinal Sciences, Hope Hospital, Salford, UK. andrew.robinson@srht.nhs.uk
Insights
Guided self-management empowers patients with inflammatory bowel disease (IBD) to actively participate in their care. This approach can improve treatment adherence and reduce healthcare utilization for chronic disease management.
Area of Science:
- Gastroenterology
- Chronic Disease Management
- Health Psychology
Background:
- Inflammatory bowel disease (IBD) management relies heavily on specialist clinician visits, leading to patient disempowerment and disengagement.
- Current appointment systems are inefficient for relapsing/remitting conditions, causing patient inconvenience and noncompliance.
- Self-care is a fundamental aspect of health, with formalized guided self-management showing promise.
Purpose of the Study:
- To explore the effectiveness and patient acceptability of guided self-management strategies for inflammatory bowel disease.
- To identify barriers and facilitators to implementing guided self-management in IBD care.
- To assess the impact of guided self-management on health service utilization and patient outcomes.
Main Methods:
- Review of recent studies on guided self-management in stable ulcerative colitis.
- Analysis of patient and clinician perspectives on shared decision-making in chronic disease management.
- Exploration of potential barriers, including clinician reluctance and patient preferences.
Main Results:
- Guided self-management in stable ulcerative colitis patients led to reduced healthcare service use.
- Patients experienced faster access to treatment and high acceptability of self-management approaches.
- No compromise in health outcomes was observed in studies of guided self-management.
Conclusions:
- Guided self-management offers a promising approach to improve inflammatory bowel disease care by enhancing patient compliance and engagement.
- Addressing barriers, such as clinician hesitancy and patient preferences, is crucial for successful implementation.
- Further research is needed to confirm long-term outcomes, but initial indications suggest improved patient responsibility and well-being.
Abstract:
Inflammatory bowel disease, in common with most chronic diseases, is managed by specialist clinicians during regular clinic follow-up visits. Patients spend approximately 1 h per year with clinicians, with few provisions made for patient participation in their own management for the remainder of the year, resulting in dependence and disempowerment. The provision of regular, fixed clinic appointments for diseases that follow an unpredictable relapsing/remitting pattern results in inefficiencies for health services and inconvenience for patients, as well as high rates of noncompliance. Self-care is a normal human function and accounts for the management of three-quarters of all episodes of ill health. More formalized applications include patients and doctors working collaboratively to develop a set of guidelines which patients use to manage their chronic disease themselves. Recent studies have shown that, in patients with stable ulcerative colitis, self-management results in reduced health service utilization, speedier access to treatment and high levels of patient acceptability, without compromising health outcomes. There are a number of barriers to the effective implementation of guided self-management at many levels. Clinicians may be reluctant to pass control of treatment changes to patients, particularly the use of steroids. Access to clinics at short notice may be difficult and some patients themselves prefer a system in which all decisions are made by doctors. Research into guided self-management is ongoing as the long-term outcomes are uncertain. However, there are indications that passing 'ownership of management' back to patients may improve compliance as patients realize their own responsibilities for remaining well.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Crohn's Disease
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
